510(k) Report

510(k) · Cleared

Recalled · 2006

IMX CA 15-3

K964407510(k) TraditionalCleared Nov 10, 1997371-day reviewClass II21 CFR 866.6010Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · MOI System, Test, Immunological, Antigen, Tumor

Cleared on Nov 10, 1997 after a 371-day review. The FDA summary names its predicate without a number. It has been recalled 3 times.

Decided
Nov 10, 1997
Review
371 days
Class
Class II
Product code
MOI
Recalls
3
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K964407Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MOI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MOI device

  1. #1 K240403 Access BR Monitorscore 7.9 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—BIOMIRA Diagnostics Inc. TRUQUANT BR RIA
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 9, 2006Not classifiedZ-1244-06OtherThe CA 15-3 Controls replicates out of range high resulting in invalid runs.
Mar 4, 2003Not classifiedZ-0681-03OtherThe CA 15-3 Calibrators may cause depressed values for the CA 15-3 High Control and for patient specimens.
Mar 4, 2003Not classifiedZ-0680-03OtherThe CA 15-3 Calibrators may cause depressed values for the CA 15-3 High Control and for patient specimens.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MOI devices

MOI System, Test, Immunological, Antigen, Tumor: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MOI

2in 2024

2007: 12011: 12018: 22019: 12020: 22024: 2
2007high 2 (2018) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MOI

Too few MOI 510(k)s in any year since 2007 to give a median.

Recalls per year · MOI

2in 2012

2007: 12012: 2
2007high 2 (2012) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MOI

6in 2025

2007: 22008: 32009: 32010: 222011: 32012: 42013: 32014: 522015: 282016: 52017: 72018: 12019: 52020: 112021: 162022: 162023: 62024: 52025: 6
2007high 52 (2014) · low 1 (2018)2025

MAUDE reports naming product code MOI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—12
20080—03
20090—03
20100—022
20111—03
20120—24
20130—03
20140—052
20150—028
20160—05
20170—07
20182—01
20191—05
20202—011
20210—016
20220—016
20230—06
20242—05
20250—06
20260—0—

What is it indicated for?

The IMx® CA 15-3™ assay is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative measurement of CA 15-3 assay values in human serum and plasma (EDTA) to aid in the management of Stage II and III breast cancer patients. Serial testing for patient CA 15-3 assay values should be used in conjunction with other clinical methods for monitoring breast cancer.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964407: IMX CA 15-3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K964407

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026